Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relationship between HBV lamivudine resistance and HBV genotypes or basic core promoter mutations.

Hepatobiliary & pancreatic diseases international : HBPD INT - 1 Feb 2003

Zhou Dong-Yao, Lin Lian-Ying, Wang Hong, Huang Jian-Sheng

Abstract excerpt

OBJECTIVE: To investigate the relationship between HBV lamivudine resistance and HBV genotypes or basic core promoter (BCP) mutations. METHODS: The common coated probes were synthesized according to the conserved regions of the preC gene of hepatitis B virus (HBV). Different colorized probes were chosen from the sequences of different genotypes of HBV (A to F), BCP and YMDD wild types and mutants, respectively....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Base Sequence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genotype

Share to Hepatitis B virus

Share to Lamivudine

Share to Molecular Sequence Data

Source

Identifiers

PMID: 14607654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relationship between HBV lamivudine resistance and HBV genotypes or basic core promoter mutations.PMID 14607654Read ↗

Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.Semantic proximity Read ↗

[The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].Semantic proximity Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

HBV resistant to lamivudine: experimental and clinical studies.Semantic proximity Read ↗

YMDD mutations and genotypes of hepatitis B virus in northern China.Semantic proximity Read ↗

Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.Semantic proximity Read ↗

Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China.Semantic proximity Read ↗

Significance of viral load, core promoter/precore mutations and specific sequences of polymerase gene in HBV-infected patients on 3-year lamivudine treatment.Semantic proximity Read ↗

Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D.Semantic proximity Read ↗

[Clinical and virologic characteristics of lamivudine resistance in HBV-associated chronic liver disease].Semantic proximity Read ↗

Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C.Semantic proximity Read ↗

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.